Utama › Kanser Perut
Kajian klinikal Kanser Perut sedang mengambil peserta di AS
134 kajian untuk Kanser Perut sedang mengambil peserta di lokasi seluruh Amerika Syarikat.
Bandar dengan paling banyak kajian
- Houston, TX42 kajian
- Boston, MA32 kajian
- New York City, NY31 kajian
- Nashville, TN28 kajian
- Los Angeles, CA22 kajian
- Baldwin Park, CA22 kajian
- Arlington, VA20 kajian
- Dallas, TX19 kajian
- San Antonio, TX19 kajian
- Grand Rapids, MI18 kajian
- St. Louis, MO18 kajian
- Washington, DC16 kajian
- Detroit, MI16 kajian
- Chicago, IL16 kajian
- Philadelphia, PA15 kajian
- Atlanta, GA14 kajian
- Pittsburgh, PA14 kajian
- Portland, OR13 kajian
- Orange, CA13 kajian
- Denver, CO12 kajian
- Mountain View, CA12 kajian
- Cleveland, OH12 kajian
- Madison, WI11 kajian
- Austin, TX10 kajian
- Orlando, FL10 kajian
- Queens, NY10 kajian
- Seattle, WA10 kajian
- Durham, NC10 kajian
- Aurora, CO10 kajian
- Oklahoma City, OK10 kajian
- Edison, NJ9 kajian
- Phoenix, AZ9 kajian
- San Diego, CA9 kajian
- Omaha, NE9 kajian
- Kansas City, MO9 kajian
- Tampa, FL9 kajian
- Columbus, OH9 kajian
- Santa Monica, CA9 kajian
- Rochester, MN9 kajian
- Minneapolis, MN9 kajian
Mengikut negeri
- Alabama6 kajian
- Alaska4 kajian
- Arizona13 kajian
- Arkansas6 kajian
- California69 kajian
- Colorado23 kajian
- Connecticut10 kajian
- Delaware4 kajian
- Florida38 kajian
- Georgia16 kajian
- Idaho3 kajian
- Illinois19 kajian
- Indiana10 kajian
- Iowa8 kajian
- Kansas8 kajian
- Kentucky9 kajian
- Louisiana5 kajian
- Maine3 kajian
- Maryland20 kajian
- Massachusetts34 kajian
- Michigan35 kajian
- Minnesota18 kajian
- Missouri23 kajian
- Montana4 kajian
- Nebraska9 kajian
- Nevada5 kajian
- New Jersey12 kajian
- New Mexico5 kajian
- New York38 kajian
- North Carolina21 kajian
- North Dakota4 kajian
- Ohio24 kajian
- Oklahoma11 kajian
- Oregon14 kajian
- Pennsylvania30 kajian
- Rhode Island5 kajian
- South Carolina9 kajian
- South Dakota4 kajian
- Tennessee30 kajian
- Texas60 kajian
- Utah14 kajian
- Virginia27 kajian
- Washington14 kajian
- West Virginia4 kajian
- Wilayah Columbia4 kajian
- Wisconsin18 kajian
Kajian yang dikemas kini baru-baru ini
Teks kajian rasmi (Bahasa Inggeris)
Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma
Mengambil pesertaKajian pemerhatian
Umur 2 hingga 100 · Semua jantina · Dikemas kini 2 Okt 2026 · NCT01950572Distance-Based Exercise to Preserve Function and Prevent Disability
Mengambil peserta
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT07059884Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays
Mengambil pesertaSukarelawan sihat dialu-alukan
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT07283939Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including Mesothelioma
Mengambil pesertaFasa 1
Umur 18 hingga 120 · Semua jantina · Dikemas kini 2 Okt 2026 · NCT06885697Phase 1/2 Study of BHB810 in Advanced Gastric and GEJ Adenocarcinoma
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT07529808Surgery in Gastrointestinal Stromal Tumors (GISTs) for Treatment, Tumor Modeling, and Genomic Analysis
Mengambil pesertaKajian pemerhatian
Umur 6 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT04557969Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
Umur 40 hingga 75 · Semua jantina · Dikemas kini 2 Okt 2026 · NCT05334069A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT06760819A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
Mengambil pesertaFasa 1
Umur 19 ke atas · Semua jantina · Dikemas kini 1 Okt 2026 · NCT06586957Obtaining Solid Tumor Tissue From People Having Biopsy or Surgery for Certain Types of Cancer
Mengambil pesertaKajian pemerhatian
Umur 2 ke atas · Semua jantina · Dikemas kini 1 Okt 2026 · NCT01915225A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 1 Okt 2026 · NCT06172478A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)
Mengambil pesertaFasa 2/3
Umur 18 ke atas · Semua jantina · Dikemas kini 30 Sep 2026 · NCT07221149AZD0901 in Participants With Advanced Solid Tumours Expressing Claudin18.2
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 30 Sep 2026 · NCT06219941A Phase 1, First-in-Human (FIH), Open-Label, Dose-Escalation and Dose Expansion Study of the Peptide Drug Conjugate (PDC), TS-104, as a Monotherapy in Subjects With Select Advanced Solid Tumors
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 30 Sep 2026 · NCT07814248Phase 3 Study of Cadonilimab Combined With Chemotherapy vs Chemotherapy in Combination With or Without Nivolumab for the 1L Treatment of Participants With HER2-negative, Previously Untreated, Unresectable or Metastatic Gastric/GEJ Adenocarcinoma
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 29 Sep 2026 · NCT07700979Anti-Ly6E Exatecan ADC M7437 in Advanced Solid Tumors
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 29 Sep 2026 · NCT07360314A Phase 1 Study of IM-1617 in Participants With Advanced Cancer
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 29 Sep 2026 · NCT07578571IKS014 in Advanced Solid Tumors That Express HER2
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 28 Sep 2026 · NCT05872295Symbiotic-GI-16: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Gastroesophageal Cancer
Mengambil pesertaFasa 2/3
Umur 18 ke atas · Semua jantina · Dikemas kini 28 Sep 2026 · NCT07392892Study of AZD5863 in Adult Participants With Advanced or Metastatic Solid Tumors
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT06005493Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 24 Sep 2026 · NCT06047379A Study of Novel Agents or Combinations as Perioperative Treatment in Participants With Locally Advanced Resectable Gastroesophageal Adenocarcinoma
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 24 Sep 2026 · NCT07069712Clinical Trial of YH32367 in Patients With HER2 Positive Locally Advanced or Metastatic Solid Tumor
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 24 Sep 2026 · NCT05523947Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
Mengambil pesertaFasa 2
Umur 18 hingga 130 · Semua jantina · Dikemas kini 23 Sep 2026 · NCT05489211A Study of Cadonilimab Combined With Chemotherapy in People With Gastric or Gastroesophageal Junction Cancer
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 23 Sep 2026 · NCT07631000Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.